Categories AlphaGraphs, Earnings, Health Care
LLY Earnings: Highlights of Eli Lilly’s Q2 2024 financial report
Eli Lilly and Company (NYSE: LLY) on Thursday reported a double-digit increase in revenues and profit for the second quarter of 2024. The pharma giant also raised its full-year guidance.
Worldwide revenue increased 36% annually to $11.3 billion in the June quarter, driven mainly by strong sales of Mounjaro, Zepbound, and Verzenio.
Second-quarter reported net income increased 68% from last year to $3.0 billion, or $3.8 per share. Adjusted earnings climbed 86% year-over-year to $3.92 per share.
The management raised its full-year revenue guidance to the range of $45.4 billion to $ 46.6 billion. EPS forecast and adjusted EPS forecast have been raised to $15.10-15.60 and $16.10-16.60, respectively.
Prior Performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
After a positive year, what 2025 holds for IBM?
International Business Machines Corporation (NYSE: IBM) has delivered impressive financial performance in 2024 by focusing on higher-value businesses. The company’s software business experienced stable growth, offsetting softness in its consulting
What to expect when Delta Air Lines (DAL) reports Q4 2024 earnings
Shares of Delta Air Lines (NYSE: DAL) fell 2% on Friday. The stock has gained 17% over the past three months. The airline is scheduled to report its earnings results
Walgreens Boots Alliance expected to report mixed Q1 2025 results
For Walgreens Boots Alliance, Inc. (NASDAQ: WBA), 2024 was a challenging year as it lost market share to competitors and closed several stores amid persistent operational headwinds. It is expected
